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ABSTRACT
Background Mathematical modelling has indicated that
expansion of male circumcision services in high HIV
prevalence settings can substantially reduce population-
level HIV transmission. However, these projections need
revision to incorporate new data on the effect of male
circumcision on the risk of acquiring and transmitting
HIV.
Methods Recent data on the effect of male circumcision
during wound healing and the risk of HIV transmission to
women were synthesised based on four trials of
circumcision among adults and new observational data
of HIV transmission rates in stable partnerships from
men circumcised at younger ages. New estimates were
generated for the impact of circumcision interventions in
two mathematical models, representing the HIV
epidemics in Zimbabwe and Kisumu, Kenya. The models
did not capture the interaction between circumcision,
HIV and other sexually transmitted infections.
Results An increase in the risk of HIV acquisition and
transmission during wound healing is unlikely to have
a major impact of circumcision interventions. However, it
was estimated that circumcision confers a 46%
reduction in the rate of male-to-female HIV transmission.
If this reduction begins 2 years after the procedure, the
impact of circumcision is substantially enhanced and
accelerated compared with previous projections with no
such effectdincreasing by 40% the infections averted
by the intervention overall and doubling the number of
infections averted among women.
Conclusions Communities, and especially women, may
beneﬁt much more from circumcision interventions than
had previously been predicted, and these results provide
an even greater imperative to increase scale-up of safe
male circumcision services.
BACKGROUND
Since three randomised controlled trials demon-
strated that adult male circumcision reduces men’s
chance of HIV acquisition by about 60%,
1e3 there
has been substantial interest in developing and
expanding services that provide male circumcision
as an additional HIV prevention strategy.
4 An
important part of the planning and strategic deci-
sion-making process for expanding circumcision
services has been quantifying the expected impact
such interventions might have on the rate of new
HIV infections in populations, and several mathe-
matical models have been developed to generate
estimates.
5e9 To guide HIV prevention policy
decisions, these estimates are compared with others
that evaluate different prevention strategies, such
as scaling-up testing and counselling services,
10 11
campaigns with messages about abstinence,
condom use and reducing multiple partners,
12 13
and universal HIV testing with immediate initia-
tion of antiretroviral therapy (ie, ‘Universal Test
and Treat’).
14 15
Previous modelling of the impact of male
circumcision on population-level HIV had two
important limitations: lack of data about the rate of
HIV transmission (both female-to-male and male-
to-female) before the wound has healed, and the
long-term effect of male circumcision on risk of
male-to-female transmission. We hypothesised that
these limitations resulted in substantial imprecision
in the estimate of the impact of circumcision
interventions on HIV spread, both overall and
especially among women.
Recently, new data have become available to
addresstheselimitations.Apooledanalysisfromthe
threetrialsevaluatingtheeffectofmalecircumcision
on female-to-male HIV transmission found that sex
before the wound has healed was associated with
atransientincreasedriskofHIVacquisitioninmen.
16
In addition, two recent studies have reported on the
relationship between male circumcision and male-
to-female HIV transmission. The ﬁrst, a randomised
trial of circumcision from Uganda, found no short-
term beneﬁt of circumcision (ie, to 24 months after
theoperation)andsomesuggestionofincreasedHIV
transmission risk to women from circumcised HIV-
infected men who resumed sex before the wound
was healed.
17 The second, an observational analysis
from a cohort of 3408 HIV-discordant couples from
14 sites in eastern and southern Africa followed for
up to 2 years, found that male-to-female HIV
transmission risk was 41% lower from circumcised
men compared with uncircumcised men (relative
transmission rate of 0.59 (95% CI 0.31 to 1.13); the
correspondingestimateadjustedforviralloadis:0.60
(95% CI 0.31 to 1.16)).
18 These data mirror those
fromanearlierobservationalstudyinRakai,Uganda
that found a relative male-to-female HIV trans-
mission rate of 0.41 (95% CI 0.10 to 1.14) in couples
with circumcised versus uncircumcised HIV-
infected men.
19 Together, these data suggest that
association between circumcision and male-to-
female HIV transmission risk is inﬂuenced by the
timing of circumcision, with recent circumcision
offering no beneﬁt, but circumcision at an earlier age
(and thus a longer interval between surgery to sex)
signiﬁcantly reducing HIV transmission risk to
female partners.
< Additional tables and ﬁgures
are published online only. To
view these ﬁles please visit the
journal online (http://sti.bmj.
com).
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EpidemiologyTo explore the implications of these new observations for the
estimates of the potential impact of circumcision interventions,
we adapted two previous published mathematical modelsdby
Hallett et al
6 for Zimbabwe and Alsallaq et al
20 for Kisumu,
Kenya.
METHODS
Full descriptions of the two mathematical models have already
been published,
6 20 and brief descriptions are provided here.
Model 1: Zimbabwe (Hallett et al)
This model is a deterministic compartmental representation of
the heterosexual spread of HIV in Zimbabwe, with HIV preva-
lence of w20% and initially low rates of circumcision.
21 To
capture the heterogeneity in the number of sexual partners, men
and women in the model were stratiﬁed into risk groups. Men and
women form partnerships so that it is more likely that high-risk
individuals form partnerships with one another. Published data
from eastern Zimbabwe
22 were used to inform these parameters
specifying sexual behaviour (although the broad behavioural
patterns are similar to reports in other settings). Based on obser-
vational data from other longitudinal studies,
23 the course of
infection is represented by individuals progressing through several
stages: acute infection (short duration, high infectiousness),latent
infection (long duration, low infectiousness) and pre-AIDS (short
duration,highinfectiousness).TheZimbabwemodelwasﬁttedto
boththeantenatalclinicprevalencedataandtheDemographicand
Health Surveys prevalence estimate.
Model 2: Kisumu, Kenya (Alsallaq et al)
This model is a deterministic compartmental representation of
the heterosexual spread of HIV in Kisumu, Kenya calibrated by
three sets of prevalence data: the Four City study population
survey data,
24 the Kenya AIDS indicator survey data for
Kisumu,
25 and the ANC surveillance data.
26 27 Before the
intervention, HIV prevalence is w15%, and 25% of adult men
are circumcised.
28 A hierarchy of effective rates of partnership
formation were used as a surrogate of sexual risk to stratify the
population into four sexual-risk groups. The effective rates of
partnership formation for females were assumed to balance
those for males, which were adjusted by ﬁtting the model to
empirical behaviour data of Kisumu.
24e27 Other parameters
were informed by empirical data, including transmission prob-
abilities per coital act per HIV stage,
23 29 frequency of coital acts
per HIV stage,
23 duration of sexual partnerships,
30 duration of
each HIV stage,
23 31 32 and fraction of the population initially in
each risk group (R H Gray, personal communication, 2008).
30 33
An important limitation is that neither model explicitly
accounts for possible interactions between circumcision and
other sexually transmitted infections (STIs).
Parameterisation of circumcision and intervention
In both models, seven independent parameters specify the effect
of circumcision on transmission (table 1; ranges for sensitivity
analysis are presented in the online supplementary table S1).
The reduction in male-to-female transmission of HIV was
assumed to begin 2 years after the operation in order to be
consistentwiththeobservationaldata,showingalargeeffect,
18 19
andtrialdata,whichdidnotﬁndevidenceforsuchaneffectwithin
2 years of the operation (recognising that the trial was not sufﬁ-
ciently powered to do so
17). In the modelled interventions, unless
otherwise speciﬁed, a constant rate of operations was assumed,
suchthat50%ofnon-circumcisedmeninagivenpopulationwere
circumcised in the ﬁrst 10 years after the start of the intervention
(HIV negative and positive men had the same chance of being
circumcised).
RESULTS
Firstly, we explored the potential impact of the risk of HIV
acquisition and transmission being higher during the wound
healing period. In a hypothetical intervention that reduced the
proportion of the population that are uncircumcised to 50% over
10 years and in which no men resume sex during wound healing,
the HIV incidence rate (new infections per person-years at risk)
in the whole population after 10 years is reduced by 20.5% in
Zimbabwe (0% circumcised before intervention) and by 7.4% in
Kisumu (25% circumcised before intervention). Alternatively,
making the most pessimistic assumptions that all men remain
sexually active throughout the wound healing period and the
mean duration of wound healing is as long as six weeks, the
incidence rate is still projected to decrease by 19% in Zimbabwe
and 6.2% in Kisumu over the same period. Differences between
the simulations decrease over time, so the long-term effect of the
elevated chance of HIV acquisition and transmission during the
circumcision wound healing period is likely to be even less.
Next we conducted a meta-analysis of data from the two
independent observational cohorts
19 36 on the long-term effect
of male circumcision on male-to-female HIV transmission. The
overall ﬁxed-effect point-estimate hazard rate was 0.54 (95% CI
0.31 to 0.96) (p¼0.04), indicating 46% reduction in transmission
rate from 2 years after the operation. There was no evidence for
heterogeneity in effect size (p¼0.61).
On the basis of the meta-analysis results, we explored the
impact of the reduction in the rate of transmission from
Table 1 Parameters specifying the effect of male circumcision on the rate of HIV transmission (ranges used in the uncertainty analysis are presented
in table S1 in the online technical appendix)
Parameter description Value Source
Mean duration of wound healing period 14 days (95% healed within 6 weeks). 34
Change in the rate of female-to-male HIV transmission before wound is healed
versus before circumcision
Increases 3-fold 16
Change in rate of HIV male-to-female HIV transmission before wound is healed
versus before circumcision
Increases 3.5-fold 17
Proportion of men who remain sexually active during the wound healing period 13% 16
Change in rate of female-to-male HIV transmission after the wound has healed
versus before circumcision
Decreases by 65% 35
Change in rate of male-to-female HIV transmission before 2 years after the operation
versus before circumcision
No effect 17
Change in rate of male-to-female HIV transmission from 2 years after the operation
versus before circumcision
We estimated this after performing a meta-analysis of data from the
two studies among HIV sero-discordant couples that measured this effect
18 19
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Epidemiologycircumcised HIV-infected men to their uninfected female part-
ners, after the wound healing period and the subsequent 2 years
(as deﬁned in the Methods). Assuming ﬁrst no effect of circum-
cision on male-to-female transmission and using best estimates
for the duration of wound healing (table S1), our simulations
suggest that the incidence rate would decrease by 19.8% in
Zimbabwe or 9.4% in Kisumu after 20 years. Then, assuming an
estimated 46% reduction in male-to-female transmission rate
associated withcircumcision, starting2 years aftertheprocedure,
corresponding estimates for the reduction in incidence are 28.0%
(Zimbabwe) and 16.8% (Kisumu) (ﬁgure 1A,B). This is an
increase in epidemiological impact of at least 40% overall.
As expected, the reduction in incidence with the male-to-
female transmission effect is most enhanced among women
(ﬁgure 1C,D). Without an effect of circumcision on male-to-
female HIV transmission, incidence is reduced among women by
11.7% in Zimbabwe or 3.9% in Kisumu after 20 years; but, with
the direct effect on male-to-female transmission, incidence is
instead reduced by 23.7% (Zimbabwe) or 13.9% (Kisumu). Thus
the epidemiological impact among women at least almost
doubles.
The number of operations required for each HIV infection
averted is also substantially reduced if there is a long-term
reduction in male-to-female transmission of HIV as a result of
male circumcision: in Zimbabwe, from 11 operations per infec-
tion averted after 20 years if there is no effect on transmission to
eight operations (down 28%); and, in Kisumu, from 14 opera-
tions per infection to eight operations over the same period
(down 41%).
The multivariate uncertainty was used to determine how the
uncertainty in the estimated effects of circumcision propagates
to the projections in epidemiological impact (Zimbabwe model
only, but qualitatively similar results would be expected for the
Kisumu model). With the original assumptions (no effect of
wound healing and no effect on male-to-female HIV trans-
mission), the uncertainty intervals for the reduction in incidence
after 20 years are 15e32% overall and 9e21% among women.
The new empirical data (table S1) support corresponding
updated estimates of 22e43% reduction in incidence overall, and
a1 5 e39% reduction among women (ﬁgure 2).
If there is no effect of circumcision on male-to-female trans-
mission and a moderate degree of increased risk behaviour
following the operation, then it is possible that HIV incidence
among women and the population overall could increase
following the intervention (online supplementary ﬁgure S1)d
a serious adverse outcome. However, assuming a 46% reduction
in the transmission rate with circumcision (2 years after the
operation), then our modelling suggests that even very high
degrees of increased risk among circumcised men would not lead
to increases in incidence overall under the intervention.
DISCUSSION
Our synthesis of new data about the effect of circumcision on
female-to-male and male-to-female HIV transmission provides
an even greater imperative to increase scale-up of circumcision
interventions to prevent HIV.
37 38 We found that (a) a transient
increased risk of HIV transmission (in both directions) during
Figure 1 Estimated reduction in
incidence following circumcision
interventions among the whole adult
population (A,B) and women (C,D), in
Zimbabwe (model 1) and Kisumu, Kenya
(model 2), respectively. It is assumed
that circumcision reduces the chance of
male-to-female transmission by 0%
(solid line) and 46% (dashed lines). For
the other assumptions, see the text.
Figure 2 Multivariate uncertainty analysis of the reduction in HIV
incidence 20 years after a circumcision intervention starts, among the
whole adult population (A) and women (B). The solid line shows the
estimate making the original assumptions (ie, only the effect of
circumcision on the chance of acquisition after the wound heals); the
dashed line shows the updated estimates using the new information (ie,
includes effect of circumcision on acquisition/transmission during wound
healing and effect on male-to-female transmission after wound healing).
Distributions for the parameters are shown in the online supplementary
table S1.
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Epidemiologythe circumcision wound healing period resulted in only a negli-
gible effect on HIV incidence rate in populations, (b) potential
long-term reduced risk of HIV transmission from HIV-infected
circumcised men ampliﬁed the beneﬁts of circumcision imple-
mentation, and (c) the beneﬁts of circumcision in these scenarios
were particularly great for women.
While short-term increased risk for both female-to-male and
male-to-female HIV transmission may occur while the wound
heals, this effect is very unlikely to materially affect the impact
of circumcision interventions at the population level. Nonethe-
less, careful communication strategies should still be used to
promote abstinence for at least 2 months after the operation to
minimise the chance of HIV transmission to female partners.
Our meta-analysis of the best available cohort data suggests
that male circumcision reduces the chance of male-to-female
HIV transmission with a latent interval of at least 2 years,
18 19
and that this substantially ampliﬁes the potential impact of
circumcision interventions in populations. Our new projections
for the reduction in HIV incidence following circumcision
interventions are 40% greater in Zimbabwe and 79% greater for
Kisumu, and the number of operations required per infection
averted is reduced by more than 25%, when the overall beneﬁti n
reduced HIV male-to-female transmission was included. This
increases the already attractive cost-saving potential of circum-
cision interventions.
83 9(In the online supplementary text S1,
we have also provided a simple formula for making a calculation
of operations per infection averteddie, generalised to other
settings.) Indeed, the combination of the two separate effects of
circumcision (reducing the chance that men acquire HIV infec-
tion and reducing the chance that infected men pass on HIV
infection) leads to a more powerful effect than would be
expected on the basis of considering the two effects separately
(ﬁgure S2).
Importantly, our simulations show very signiﬁcantly that the
beneﬁt of circumcision interventions to women is greatly
increased. Although it was previously expected that women
would beneﬁt modestly from male circumcision implementation
(as fewer of their sexual partners would be infected
6), these new
projections show that women could also receive a direct beneﬁt
from circumcision. Earlier work had predicted that the popula-
tion impact of circumcision intervention would be sensitive to
this factor.
39 40 If our estimate about the long-term effect of
circumcision on male-to-female transmission is correct, then
women in stable partnerships with infected men would receive
a degree of protection from circumcision similar to that received
by men in partnerships with infected women. We note,
however, that the standard of evidence for an effect on male-to-
female transmission (meta-analysis of two cohort studies) is
much less than that for the effect of circumcision on men’s
chance of acquiring HIV infection (three randomised trials and
more than 36 observational studies
35). Our results do not indi-
cate that HIV-infected men should be targeted for circumcision,
as most of the impact of the reduction in male-to-female
transmission comes through reducing onward transmission of
‘break-through’ infections among men circumcised when they
were not infected (if only uninfected men are circumcised in the
intervention, the eventual reduction in incidence is increased by
30% overall and 66% for women, compared with 44% and 95%,
respectively, if HIV-infected men are circumcised too). Thus, our
ﬁndings support the current UNAIDS recommendations that
men seeking circumcision who are already HIV infected be
discouraged but not refused the operation.
In addition, earlier concerns about women being exposed to
increased risk due to risk compensation among circumcised men
are substantially allayed. Our calculations show that it is
unlikely that risk compensation following circumcision will
undermine the beneﬁts for either men or women.
We adapted two previously developed mathematical models,
both of which make a number of simplifying assumptions about
the pattern of sex partner contact and HIV natural history, but
which have nevertheless proved useful in developing recom-
mendations and strategic decision-making in male circumcision
interventions.
20 37 40 41 Application of the same analysis to two
independently constructed models, parameterised for different
settings, also indicates that our ﬁndings are not speciﬁc to one
type of modelling approach or one population. There are simi-
larities in the model structure (both are deterministic compart-
mental transmission models which include stratiﬁcation by risk
group and an account of mixing in sexual contact between risk
groups), but substantial differences remain, besides parameter-
isation, such as the way that the force of infection is calculated
and the assumption made about entry and exit to different risk
categories. The impact of circumcision interventions is some-
what less in Kisumu (model 2) than in Zimbabwe (model 1),
because the basic reproductive ratio is estimated to be higher in
Kisumu (this reduces the impact of many types of interven-
tion
42) and 25% of men in Kisumu are already circumcised.
20
These results should not be interpreted as literal forecasts for
either setting, as the rate of scale-up of circumcision that will be
achieved is far from certain, and the imprecision in the speciﬁca-
tion of the epidemiological conditions was not fully quantiﬁed.
43
An important limitation is that neither model explicitly
accounts for possible interactions between circumcision and
other STIs.
44 Therefore the beneﬁts of circumcision interven-
tions in reducing the incidence of other STIs cannot be quanti-
ﬁed here. Any indirect effects on HIV incidence that accrue
through reduced STI prevalence will also not be captured in the
models, so our results may in fact underestimate the impact of
the interventions. However, earlier work indicates that the
strength of those indirect effects is expected to be small relative
to the direct effect of circumcision on HIV acquisition (and
transmission).
44 45
Indirect observational data have produced conﬂicting evidence
on the effect of circumcision on male-to-female HIV trans-
mission, but most studies were severely limited by a lack of
knowledge on the circumcision or infection status of men.
37 A
recent meta-analysis included data from the Rakai randomised
controlled trial among HIV-infected men
17 and six longitudinal
studies, with 95% CI 0.53 to 1.36 (point estimate 0.80).
46 In this
paper, we have restricted analyses to the only two longitudinal
studies that directly measured rates of transmission from
HIV-infected men of known circumcision status at the time of
study entry to their regular partners.
18 19 Both found evidence
for a reduction in transmission, although small numbers limited
statistical signiﬁcance in each study when analysed separately.
Our meta-analysis of these highly comparable datasets,
however, provides statistically signiﬁcant evidence of a true
effect. The uncertainty in the estimated effect size was, never-
theless, fully represented in this analysis (ﬁgure 2). The Rakai
trial
17 showed no efﬁcacy in the 2 years of follow-up of female
partners after their male partners were circumcised, suggesting
that it may take time for keratinisation of the scar and glans or
other biological changes to develop, and here we assumed that
the effect developed 2 years after the operation. Encouragingly,
more data will become available from on-going HIV vaccine
trials
47e49 and other studies, which will help to hone our
knowledge about the effect of circumcision and reﬁning model
projections.
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interventions on population-level HIV may need to be dramat-
ically revised: the impact of male circumcision implementation
could be realised much sooner and with greater cost-efﬁciency
than had previously been thought. It is also crucial to recognise
and communicate that, although male circumcision is an inter-
vention applied to men, it brings substantial beneﬁts for women
as well. Premature resumption of sexual activity before the
wound is healed or ‘compensatory’ increases in risk following
circumcision are both unlikely to substantively undermine the
beneﬁts of male circumcision on HIV incidence among women
or men.
Acknowledgements We thank The Wellcome Trust (TBH) and the US National
Institutes of Health (grant 1R01AI083034) and Qatar National Research Fund (NPRP
08-068-3-024) (TBH and LA-R) for funding support. The funders had no role in study
design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Funding Wellcome Trust + NIH.
Competing interests None.
Provenance and peer review Not commissioned; externally peer reviewed.
REFERENCES
1. Auvert B, Taljaard D, Lagarde E, et al. Randomized, controlled intervention trial of
male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med
2005;2:e298.
2. Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in
Rakai, Uganda: a randomised trial. Lancet 2007;369:657e66.
3. Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young
men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007;369:643e56.
4. WHO, UNAIDS. New Data on Male Circumcision and HIV Prevention: Policy and
Programme Implications. http://www.data.unaids.org/pub/Report/2007/
mc_recommendations_en.pdf (accessed 3 Feb 2011).
5. Williams BG, Lloyd-Smith JO, Gouws E, et al. The potential impact of male
circumcision on HIV in Sub-Saharan Africa. PLoS Med 2006;3:e262.
6. Hallett TB, Singh K, Smith JA, et al. Understanding the impact of male circumcision
interventions on the spread of HIV in southern Africa. PLoS ONE 2008;3:e2212.
7. White RG, Glynn JR, Orroth KK, et al. Male circumcision for HIV prevention in
sub-Saharan Africa: who, what and when? AIDS 2008;22:1841e50.
8. Kahn JG, Marseille E, Auvert B. Cost-effectiveness of male circumcision for HIV
prevention in a South African setting. PLoS Med 2006;3:e517.
9. UNAIDS/WHO/SACEMA Expert Group on Modelling the Impact Cost of Male
Circumcision for HIV Prevention. Male circumcision for hiv prevention in high hiv
prevalence settings: what can mathematical modelling contribute to informed
decision making? PLoS Med 2009;6:e1000109.
10. WHO, UNAIDS. Guidance on provider-initiated HIV testing and counselling in health
facilities. http://www.who.int/hiv/topics/vct/PITCguidelines.pdf (accessed 3 Feb
2011).
11. Hallett TB, Dube S, Cremin I, et al. The role of testing and counselling for hiv
prevention and care in the era of scaling-up antiretroviral therapy. Epidemics
2009;1:77e82.
12. Halperin DT, Steiner MJ, Cassell MM, et al. The time has come for common ground
on preventing sexual transmission of HIV. Lancet 2004;364:1913e15.
13. Shelton JD. Why multiple sexual partners? Lancet 2009;374:367e9.
14. Granich RM, Gilks CF, Dye C, et al. Universal voluntary HIV testing with immediate
antiretroviral therapy as a strategy for elimination of HIV transmission:
a mathematical model. Lancet 2008;373:48e57.
15. Dodd PJ, Garnett GP, Hallett TB. Examining the promise of HIV elimination by ‘test
and treat’ in hyperendemic settings. AIDS 2010;24:729e35.
16. Mehta SD, Gray RH, Auvert B, et al. Does sex in the early period after circumcision
increase HIV-seroconversion risk? Pooled analysis of adult male circumcision clinical
trials. AIDS 2009;23:1557e64.
17. Wawer MJ, Makumbi F, Kigozi G, et al. Circumcision in HIV-infected men and its
effect on HIV transmission to female partners in Rakai, Uganda: a randomised
controlled trial. Lancet 2009;374:229e37.
18. Baeten JM, Donnell D, Kapiga SH, et al. Male circumcision and risk of male-to-
female HIV-1 transmission: a multinational prospective study in African HIV-1-
serodiscordant couples. AIDS 2009;24:737e44.
19. Gray RH, Kiwanuka N, Quinn TC, et al. Male circumcision and HIV acquisition and
transmission: cohort studies in Rakai, Uganda. Rakai Project Team. AIDS
2000;14:2371e81.
20. Alsallaq R, Cash B, Weiss H, et al. Quantitative assessment of the role of male
circumcision in HIV epidemiology at the population level. Epidemics 2009;1:139e52.
21. Hallett TB, Gregson S, Gonese E, et al. Assessing evidence for behaviour change
affecting the course of HIV epidemics: a new mathematical modelling approach and
application to data. Zimbabwe Epidemics 2009;1:108e17.
22. Gregson S, Nyamukapa CA, Garnett GP, et al. Sexual mixing patterns and
sex-differentials in teenage exposure to HIV infection in rural Zimbabwe. Lancet
2002;359:1896e903.
23. Wawer MJ, Gray RH, Sewankambo NK, et al. Rates of HIV-1 transmission per
coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis
2005;191:1403e9.
24. Buve ´ A, Carael M, Hayes RJ, et al. The multicentre study on factors determining the
differential spread of HIV in four African cities: summary and conclusions. AIDS
2001;15(Suppl 4):S127e31.
25. National AIDS and STI Control Programme MoH. Kenya AIDS Indicator Survey
2007: Preliminary Report. Nairobi, Kenya: National AIDS and STI Control Programme
MoH, 2008.
26. UNAIDS/WHO. AIDS epidemic update 2004. 2004.
27. WHO/AFRO. HIV/AIDS Epidemiological Surveillance Update for the WHO African
Region 2002 Country Proﬁles. 2002.
28. Auvert B, Buve ´ A, Lagarde E, et al. Male circumcision and HIV infection in four cities
in sub-Saharan Africa. AIDS 2001;15(Suppl 4):S31e40.
29. Abu-Raddad LJ, Patnaik P, Kublin JG. Dual infection with HIV and malaria fuels the
spread of both diseases in sub-Saharan Africa. Science 2006;314:1603e6.
30. Morison L, Weiss HA, Buve A, et al. Commercial sex and the spread of HIV in four
cities in sub-Saharan Africa. AIDS 2001;15(Suppl 4):S61e9.
31. Morgan D, Whitworth J. The natural history of HIV-1 infection in Africa. Nat Med
2001;7:143e5.
32. UNAIDS. UNAIDS Reference Group on Estimates, Modelling and Projections.
UNAIDS, 2007.
33. Ferry B, Carael M, Buve A, et al. Comparison of key parameters of sexual behaviour
in four African urban populations with different levels of HIV infection. AIDS
2001;15(Suppl 4):S41e50.
34. Kigozi G, Gray RH, Wawer MJ, et al. The safety of adult male circumcision in
HIV-infected and uninfected men in Rakai, Uganda. PLoS Med 2008;5:e116.
35. Weiss HA, Halperin D, Bailey RC, et al. Male circumcision for HIV prevention: from
evidence to action? AIDS 2008;22:567e74.
36. Baeten J, Donnell D, Inambao M, et al. Male Circumcision and Risk of Male-to-
Female HIV-1 Transmission: A Multinational Prospectiv Study. 5th International AIDS
Society Conference on HIV Pathogenesis, Treatment and Prevention. Cape Town,
South Africa, 19e22 July, 2009.
37. Kim S. Evaluation of impact of adult male circumcision programs on HIV incidence
and prevalence: Current research, gaps in knowledge and recommendations for
additional research. Report of a roundtable discussion convened by the forum for
collaborative HIV research in collaboration with the Bill & Melinda gates foundation,
World Health Organization, and UNAIDS. Washington, DC. Forum for Collaborative
HIV Research, 2008. http://www.hivforum.org/storage/hivforum/documents/MC2/
mc2%20report%20ﬁnal.pdf (accessed 3 Feb 2011).
38. Hankins C. Male circumcision for HIV prevention: Operational research priorities.
London: International Society for Sexually Transmitted Diseases Research, 2009.
39. Gray RH, Li X, Kigozi G, et al. The impact of male circumcision on HIV incidence and
cost per infection prevented: a stochastic simulation model from Rakai, Uganda.
AIDS 2007;21:845e50.
40. Manicaland HIV/STD Prevention Project. Mathematical modelling tools in the
response to the HIV epidemic in Zimbabwe. London & Harare, Zimbabwe: Imperial
College London & Biomedical Research and Training Institute, 2008.
41. UNAIDS/WHO/SACEMA Expert Group on Modelling the Impact Cost of
Male Circumcision for HIV Prevention. Male circumcision for HIV prevention in
high HIV prevalence settings: what can mathematical modelling contribute to
informed decision making? PLoS Med 2009;6:e1000109.
42. Garnett GP, Anderson RM. Strategies for limiting the spread of HIV in developing
countries: conclusions based on studies of the transmission dynamics of the virus.
J Acquir Immune Deﬁc Syndr Hum Retrovirol 1995;9:500e13.
43. Garnett GP, Cousens S, Hallett TB, et al. Mathematical models in the evaluation of
health programmes. Lancet. In press.
44. Desai K, Boily MC, Garnett GP, et al. The role of sexually transmitted infections in
male circumcision effectiveness against HIVeinsights from clinical trial simulation.
Emerg Themes Epidemiol 2006;3:19.
Key messages
< Circumcision may confer a 46% reduction in the rate of HIV
transmission from circumcised men to their female partners.
< Assuming a reduction in male-to-female transmission, the
projected impact of circumcision on HIV spread is substan-
tially enhanced, especially for women.
< An increase in the risk of acquisition and transmission of
HIV during circumcision wound healing is unlikely to have
a major effect on the population-level impact of circumcision
interventions.
92 Sex Transm Infect 2011;87:88e93. doi:10.1136/sti.2010.043372
Epidemiology45. Boily MC, Desai K, Masse B, et al. Incremental role of male circumcision on
a generalised HIV epidemic through its protective effect against other sexually
transmitted infections: from efﬁcacy to effectiveness to population-level impact.
Sex Transm Infect 2008;84(Suppl 2):ii28e34.
46. Weiss HA, Hankins CA, Dickson K. Male circumcision and risk of HIV infection in
women: a systematic review and meta-analysis. Lancet Infect Dis 2009;9:669e77.
47. Gray GE, Kublin JG. Safety and Efﬁcacy of a Three-Dose Regimen of an Adenoviral HIV
Vaccine (MRKAd5 HIV-1 Gag/Pol/Nef) in HIV Uninfected South African Adults. 2007.
http://www.clinicaltrials.gov/ct/show/NCT00413725;jsessionid¼A6758E80AEA5A1111E
76F301C01DE11E?order¼2 (accessed 3 Feb 2011).
48. Pitisuttithum P, Gilbert P, Gurwith M, et al. Randomized, double-blind, placebo-
controlled efﬁcacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine
among injection drug users in Bangkok, Thailand. J Infect Dis 2006;194:1661e71.
49. Rerks-Ngarm S, Brown AE, Khamboonruang C, et al. HIV/AIDS preventive vaccine
‘prime-boost’ phase III trial: foundations and initial lessons learned from Thailand.
AIDS 2006;20:1471e9.
Letter
Sex Transm Infect March 2011 Vol 87 No 2 93
Epidemiology